Theory and practice in the treatment of heart failure.
D000208:Acute Disease; D002395:Catecholamines / Q000378:metabolism; D002908:Chronic Disease; D004077:Digoxin / Q000627:therapeutic use*; D004232:Diuretics / Q000627:therapeutic use*; D004573:Electrolytes / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006329:Heart Conduction System / Q000503:physiopathology; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism; D010646:Phentolamine / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002395:Catecholamines; D004232:Diuretics; D004573:Electrolytes; D005227:Fatty Acids; D010726:Phosphodiesterase Inhibitors; D014665:Vasodilator Agents; D004077:Digoxin; D005947:Glucose; D010646:Phentolamine